<div id="readability-page-1">Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy underperformed its benchmark, the Russell Midcap® Growth Index, in the third quarter of 2025, which increased approximately 3%. In addition, please check the fund’s top five holdings […]</div>

阿里拉姆制藥

<p>Brown Advisory 的中型股增長策略在 2025 年第三季度表現不及羅素中型股增長指數，該指數上漲了 3%。阿里拉姆製藥（ALNY）在此期間大幅上漲，投資者信中對此進行了強調。信中提供了基金的主要持股和表現的見解</p>

以下是阿里拉姆製藥（ALNY）在第三季度股價飆升的原因